Rationality of the ethanol precipitation process in modern preparation production of Zishui‐Qinggan decoction evaluated by integrating UPLC‐QTOF‐MS/MS‐based chemical profiling/serum pharmacochemistry and network pharmacology
Phytochemical Analysis · 2024
DOI: 10.1002/pca.3325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemical Analysis, 2024. Verfasst von Cheng-Ying Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medi…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Tandem Mass Spectrometry, Network Pharmacology, Ethanol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Science and Technology Development Program of Traditional Chinese Medicine of Jiangsu Province, China, Traditional Chinese Medicine Inheritance and Innovation Development Demonstration Pilot Funding Project of Nanjing, China, Elderly Health Research Project of Jiangsu Province, China.
Abstract (Originalsprache)
Introduction
Zishui‐Qinggan decoction (ZQD) is a classical traditional Chinese medicine formula (TCMF) for alleviating menopausal symptoms (MPS) induced by endocrine therapy in breast cancer patients. In the production of TCMF modern preparations, ethanol precipitation (EP) is a commonly but not fully verified refining process.
Objectives
Chemical profiling/serum pharmacochemistry and network pharmacology approaches were integrated for exploring the rationality of the EP process in the production of ZQD modern preparations. Material and methods Ultra‐performance liquid chromatography–quadrupole time‐of‐flight tandem mass spectrometry (UPLC‐QTOF‐MS/MS) was applied to identify the chemical profiles and absorbed components of ZQD. Network pharmacology was used to identify targets and pathways related to MPS‐relieving efficacy.
Results
The chemicals of ZQDs without/with EP process (referred to as ZQD‐W and ZQD‐W‐P, respectively) were qualitatively similar with 89 and 87 components identified, respectively, but their relative contents were different; 51 components were detectable in the serum of rats orally administered with ZQD‐W, whereas only 19 were detected in that administered with ZQD‐W‐P. Key targets, such as AKT1, and pathways, such as the PI3K‐Akt signalling pathway, affected by ZQD‐W and ZQD‐W‐P were similar, while the neuroactive ligand–receptor interaction pathway among others and the MAPK signalling pathway among others were specific pathways affected by ZQD‐W and ZQD‐W‐P, respectively. The specifically absorbed components of ZQD‐W could combine its specific key targets.
Conclusion
The EP process quantitatively altered the chemical profiles of ZQD, subsequently affected the absorbed components of ZQD, and then affected the key targets and pathways of ZQD for relieving MPS. The EP process might result in variation of the MPS‐relieving efficacy of ZQD, which deserves further in vivo verification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Metabolomics, Jiangsu Province Academy of Traditional Chinese Medicine and Jiangsu Branch of China Academy of Chinese Medical Sciences, Nanjing, China.
- Oncology Department, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Cheng-Ying Wu, Fang Long, Song-Lin Li
Förderung
- Science and Technology Development Program of Traditional Chinese Medicine of Jiangsu Province, China
- Traditional Chinese Medicine Inheritance and Innovation Development Demonstration Pilot Funding Project of Nanjing, China
- Elderly Health Research Project of Jiangsu Province, China
- Jiangsu Clinical Innovation Center of Digestive Cancer of Traditional Chinese Medicine
Zitieren
APA
Wu, C. Y., Guo, Y. Y., Ma, Z. Y., Zhou, J., Long, F., Shen, H., Xu, J. D., Zhou, S. S., Huo, J. G., Hu, C. H., & Li, S. L. (2024). Rationality of the ethanol precipitation process in modern preparation production of Zishui‐Qinggan decoction evaluated by integrating UPLC‐QTOF‐MS/MS‐based chemical profiling/serum pharmacochemistry and network pharmacology. Phytochemical Analysis. https://doi.org/10.1002/pca.3325
Vancouver
Wu CY, Guo YY, Ma ZY, Zhou J, Long F, Shen H, et al. Rationality of the ethanol precipitation process in modern preparation production of Zishui‐Qinggan decoction evaluated by integrating UPLC‐QTOF‐MS/MS‐based chemical profiling/serum pharmacochemistry and network pharmacology. Phytochemical Analysis. 2024. doi:10.1002/pca.3325
BibTeX
@article{Wu2024,
author = {Wu, Cheng-Ying and Guo, Yi-Yin and Ma, Zhen-Yue and Zhou, Jing and Long, Fang and Shen, Hong and Xu, Jin-Di and Zhou, Shan-Shan and Huo, Jie-Ge and Hu, Can-Hong and Li, Song-Lin},
title = {Rationality of the ethanol precipitation process in modern preparation production of Zishui‐Qinggan decoction evaluated by integrating UPLC‐QTOF‐MS/MS‐based chemical profiling/serum pharmacochemistry and network pharmacology},
journal = {Phytochemical Analysis},
year = {2024},
doi = {10.1002/pca.3325}
}
EUVIMED